Form DEFA14A Revance Therapeutics,
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ý
Filed by a Party other than the Registrant ¨
Check the appropriate box:
¨ | Preliminary Proxy Statement | |||||||||||||||||||
¨ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |||||||||||||||||||
¨ | Definitive Proxy Statement | |||||||||||||||||||
ý | Definitive Additional Materials | |||||||||||||||||||
¨ | Soliciting Material Pursuant to § 240.14a-12 | |||||||||||||||||||
| Revance Therapeutics, Inc. | ||||||||||||||||||||
| (Name of Registrant as Specified in its Charter) | ||||||||||||||||||||
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||||||||||||||||||||
Payment of Filing Fee (Check all boxes that apply): | ||||||||||||||||||||
| ý | No fee required. | |||||||||||||||||||
¨ | Fee paid previously with preliminary materials. | |||||||||||||||||||
¨ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 | |||||||||||||||||||


Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin Price News: BTC Trades Near $81,600 as Remittix Nears $33 Million Raised and Its November 24 Debut
- Beware the Tax Man: Ken Jennings Wants to Tax Every Washingtonian
- XRP Price Today: XRP Near $1.30 Gets New Institutional Perpetuals Support as Remittix Pairs Payments With Live Markets
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share